This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Web of Science (1) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Wei, M. Articles by Li, Y. Search for Related Content PubMed PubMed Citation Articles by Wei, M. Articles by Li, Y. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB (L)-HISTIDINE Social Bookmarking                         What's this?

High-Throughput Determination of Mode of Inhibition in Lead Identification and Optimization

Biochemistry Group, CVU CEDD, GlaxoSmithKline Pharmaceuticals, King of Prussia, PA

Richard Wynn

Gregory Hollis

Boshan Liao

Alexander Margulis

Applied Technology Group, Incyte Corporation, Wilmington, DE

Brian G. Reid

New Leads Development Group, Myogen, Inc., Westminster, CO

Ronald Klabe

Phillip C. C. Liu

Mary Becker-Pasha

Mark Rupar

Timothy C. Burn

Dale E. McCall

Yanlong Li

Applied Technology Group, Incyte Corporation, Wilmington, DE

After finishing the primary high-throughput screening, the screening team is often faced with thousands of hits to be evaluated further. Effective filtering of these hits is crucial in identifying leads. Mode of inhibition (MOI) study is extremely useful in validating whether the observed compound activity is specific to the biological target. In this article, the authors describe a high-throughput MOI determination method for evaluating thousands of compounds using an existing screening infrastructure. Based on enzyme or receptor kinetics theory, the authors developed the method by measuring the ratio of IC₅₀ or percent inhibition at 2 carefully chosen substrate or ligand concentrations to define an inhibitor as competitive, uncompetitive, or noncompetitive. This not only facilitates binning of HTS hits according to their MOI but also greatly expands HTS utility in support of the medicinal chemistry team's lead optimization practice. Three case studies are presented to demonstrate how the method was applied successfully in 3 discovery programs targeting either an enzyme or a G-protein-coupled receptor.

Key Words: mode of inhibition • competitive • noncompetitive • high-throughput screening • leads identification and optimization

Journal of Biomolecular Screening, Vol. 12, No. 2, 220-228 (2007)
DOI: 10.1177/1087057106296679


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?